These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16538532)

  • 1. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA.
    Dell'Orto P; Biasi MO; Del Curto B; Zurrida S; Galimberti V; Viale G
    Breast Cancer Res Treat; 2006 Jul; 98(2):185-90. PubMed ID: 16538532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
    Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
    Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes.
    Martin Martinez MD; Veys I; Majjaj S; Lespagnard L; Schobbens JC; Rouas G; Filippov V; Noterman D; Hertens D; Feoli F; Bourgeois P; Durbecq V; Larsimont D; Nogaret JM
    Eur J Surg Oncol; 2009 Apr; 35(4):387-92. PubMed ID: 18639429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
    Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
    Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
    Ouellette RJ; Richard D; Maïcas E
    Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three mRNA markers for the detection of lymph node metastases.
    Berger J; Mueller-Holzner E; Fiegl H; Marth C; Daxenbichler G
    Anticancer Res; 2006; 26(5B):3855-60. PubMed ID: 17094413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
    Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
    Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of micrometastases in lymph nodes from patients with breast cancer.
    Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
    Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eighteen months clinical experience with the GeneSearch breast lymph node assay.
    Veys I; Durbecq V; Majjaj S; Schobbens JC; Noterman D; Sirtaine N; Martinez MD; Hertens D; Feoli F; Bourgeois P; Nogaret JM; Larsimont D
    Am J Surg; 2009 Aug; 198(2):203-9. PubMed ID: 19249740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammaglobin, a potential marker of breast cancer nodal metastasis.
    Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
    J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
    Wallwiener CW; Wallwiener M; Kurth RR; Röhm C; Neubauer H; Banys MJ; Staebler A; Schönfisch B; Meuer SC; Giese T; Fehm TN
    Breast Cancer Res Treat; 2011 Dec; 130(3):833-44. PubMed ID: 21858660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node molecular pathology in breast carcinoma.
    Denninghoff V; Allende D; Paesani F; Garcia A; Avagnina A; Perazzo F; Abalo E; Crimi G; Elsner B
    Diagn Mol Pathol; 2008 Dec; 17(4):214-9. PubMed ID: 18382355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.
    Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L;
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
    Wascher RA; Bostick PJ; Huynh KT; Turner R; Qi K; Giuliano AE; Hoon DS
    Br J Cancer; 2001 Nov; 85(9):1340-6. PubMed ID: 11720472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time RT-PCR in sentinel lymph nodes from melanoma patients. Detection of melanocytic mRNA predicts disease-free survival.
    Riber-Hansen R; Abrahamsen HN; Sorensen BS; Hamilton-Dutoit SJ; Steiniche T
    APMIS; 2008 Mar; 116(3):199-205. PubMed ID: 18377585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of reverse transcription-PCR quantification of cytokeratin mRNA in the detection of sentinel lymph node invasion in oral and oropharyngeal squamous cell carcinoma: a comparison with immunohistochemistry.
    Garrel R; Dromard M; Costes V; Barbotte E; Comte F; Gardiner Q; Cartier C; Makeieff M; Crampette L; Guerrier B; Boulle N
    Clin Cancer Res; 2006 Apr; 12(8):2498-505. PubMed ID: 16638858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.